Icecure Medical Ltd. current report, Q4 FY2022

Business Context and Reporting Period

This Form 6-K filing by Icecure Medical Ltd. covers the month of November 2022. The report serves to furnish a press release regarding the company's ProSense technology being featured in a poster presentation at the Radiological Society of North America's (RSNA) 2022 Annual Meeting.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or quantitative performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on a corporate development event.

Outlook, Commentary, and Risks

Management Commentary: The company highlighted the inclusion of its ProSense technology in a poster presentation at a major industry conference (RSNA 2022).
Risks and Contingencies: The filing text does not provide specific details regarding risks, contingencies, or unusual items beyond the standard incorporation by reference into existing registration statements.

Investor Verification Checklist

  • Verify the content and implications of the ProSense poster presentation at the RSNA 2022 Annual Meeting via the attached press release (Exhibit 99.1).
  • Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this Form 6-K contains none.
  • Confirm the status of the company's Registration Statements on Form F-3 and Form S-8 referenced in the filing.